How to Store Cagrilintide Long Term — Peptide Stability

How to Store Cagrilintide Long Term — Peptide Stability Guide

Research conducted at the Novo Nordisk laboratories demonstrated that cagrilintide. A long-acting amylin analogue under investigation for metabolic regulation. Maintains structural integrity for up to 24 months when stored as lyophilised powder at −20°C, but degrades within 72 hours at room temperature once reconstituted. That gap isn't academic. For researchers working with peptides, storage protocol determines whether the compound retains pharmacological activity or becomes a denatured protein with zero binding affinity.

Our team at Real Peptides has guided hundreds of research facilities through peptide storage planning. The difference between a compromised batch and a stable one comes down to three things most suppliers gloss over: thermal discipline, moisture exclusion, and freeze-thaw cycle management.

How should you store cagrilintide long term for research purposes?

Store cagrilintide long term as lyophilised powder at −20°C in a desiccated environment with light protection. Once reconstituted with bacteriostatic water, refrigerate at 2–8°C and use within 28 days. Temperature excursions above 8°C cause irreversible aggregation of the peptide backbone, rendering the compound inactive regardless of subsequent storage correction. Moisture ingress during lyophilised storage accelerates oxidation and reduces shelf life by 40–60%.

Most peptide degradation doesn't happen during active use. It happens during the transition between storage states. Lyophilised cagrilintide tolerates frozen storage remarkably well, but reconstituted peptide solutions are thermally fragile. The amylin receptor agonist structure includes disulphide bonds and beta-sheet regions that misfold irreversibly above physiological temperature ranges. What looks like clear solution in your vial may have lost 30–50% binding affinity if it spent six hours at 15°C during shipping. This guide covers the specific temperature thresholds that matter, the moisture and light exposure limits that accelerate breakdown, and the freeze-thaw mistakes that researchers consistently make when attempting to extend reconstituted peptide longevity.

Step 1: Store Lyophilised Cagrilintide Powder at −20°C in Desiccated Conditions

Lyophilised cagrilintide arrives as a white to off-white powder in sealed glass vials under partial vacuum or inert gas atmosphere. Store these vials immediately at −20°C (standard laboratory freezer temperature). Not at −80°C, which offers no additional stability benefit and risks sublimation-driven moisture ingress when vials are moved to working temperature. The peptide remains stable at −20°C for 24 months from manufacture date when kept sealed and desiccated.

Moisture is the primary degradation vector for lyophilised peptides. Even trace humidity triggers hydrolysis of peptide bonds and oxidation of methionine residues in the cagrilintide sequence. Store vials inside a sealed container with desiccant packets (indicating silica gel rated for laboratory use) to maintain relative humidity below 20%. Replace desiccant every three months or when the indicator turns from blue to pink, signalling moisture saturation.

Light exposure accelerates photodegradation of aromatic amino acids (tyrosine, tryptophan) in peptide structures. Wrap vials in aluminium foil or store in an opaque container if your freezer includes interior lighting. UV and visible light both contribute to oxidative stress pathways that fragment peptide chains over time.

Do not open vials until you're prepared to reconstitute the entire contents immediately. Each time a vial is opened, ambient moisture enters. Even briefly. Peptide powder exposed to room air for 30 seconds during handling can absorb enough water vapour to degrade 5–10% within 48 hours. If your protocol requires multiple small-volume reconstitutions, request custom aliquoting from your supplier rather than repeatedly opening a single large vial.

Step 2: Reconstitute with Bacteriostatic Water and Refrigerate Immediately at 2–8°C

Reconstitute lyophilised cagrilintide with bacteriostatic water containing 0.9% benzyl alcohol as the preservative. Never use sterile water without preservative for multi-dose vials. The benzyl alcohol inhibits bacterial growth during the 28-day use window without affecting peptide stability. Inject the bacteriostatic water slowly down the vial wall rather than directly onto the powder to minimize agitation, which can cause peptide aggregation and foam formation.

Once reconstituted, store cagrilintide solution at 2–8°C (standard refrigerator temperature) and use within 28 days. This timeline isn't arbitrary. Peptide hydrolysis and aggregation accelerate in aqueous solution even under refrigeration, reducing potency by approximately 2–4% per week after the first month. Label each vial with the reconstitution date using permanent marker and discard any solution remaining after 28 days regardless of appearance.

Temperature discipline is critical. Reconstituted cagrilintide stored above 8°C undergoes rapid structural denaturation. The amylin-mimetic confirmation unfolds, disulphide bonds rearrange, and beta-sheet regions misfold irreversibly. A vial left at 15°C for four hours loses 20–30% binding affinity permanently. There's no recovery path. Cooling the solution afterward doesn't refold the protein. This is why peptide refrigerators with digital temperature logging are essential for labs handling sensitive compounds.

Do not freeze reconstituted peptide solutions. Freezing causes ice crystal formation that physically disrupts peptide structure, leading to aggregation and precipitation upon thawing. The resulting solution may appear clear but will contain microaggregates that reduce bioavailability and can trigger immune responses in biological assays. If you need to store cagrilintide long term beyond the 28-day window, maintain it in lyophilised form and reconstitute fresh aliquots as needed.

Step 3: Prevent Freeze-Thaw Cycles and Monitor Temperature Excursions Throughout Storage

Freeze-thaw cycles are among the most common causes of peptide degradation in research settings. Each freeze-thaw event stresses the peptide backbone through ice crystal formation, osmotic pressure changes, and pH fluctuations as buffer components separate during freezing. For lyophilised cagrilintide stored at −20°C, a single inadvertent thaw (e.g., during freezer defrost or power interruption) reduces shelf life by 30–40% even if the vial is immediately refrozen.

Use a freezer equipped with temperature monitoring and alarm systems. Most laboratory-grade freezers include digital controllers that log temperature every 15 minutes and trigger audible alarms if the internal temperature rises above −15°C. For critical peptide inventories, consider installing independent temperature data loggers that record to external storage. These provide forensic evidence if you suspect thermal excursions occurred during off-hours or equipment failure.

For reconstituted peptide stored at 2–8°C, temperature excursions above 8°C must be tracked. If a vial spent two hours at 12°C due to refrigerator door left ajar or equipment malfunction, assume 10–15% potency loss and adjust experimental concentrations accordingly. There's no reliable way to measure residual potency without mass spectrometry or HPLC analysis. Temperature discipline is the only preventive control you have.

Shipping represents the highest-risk period for thermal excursions. If you're transporting reconstituted cagrilintide between facilities or receiving peptides from a supplier, use validated cold-chain shipping with real-time temperature monitoring. Gel ice packs maintain 2–8°C for 24–36 hours; dry ice maintains −20°C but requires special handling for lyophilised peptides (pressure buildup in sealed vials can cause cracking). At Real Peptides, we ship all research peptides with temperature data loggers in every package. The thermal history travels with the compound so you know exactly what conditions it experienced in transit.

How to Store Cagrilintide Long Term: Peptide Stability Comparison

Lyophilised powder (sealed)

−20°C with desiccant

24 months

Moisture ingress, light exposure

Most stable form. Prioritise this for long-term storage

Lyophilised powder (opened)

3–6 months

Repeated moisture exposure during handling

Single-use aliquots eliminate this risk entirely

Reconstituted solution

2–8°C refrigerated

28 days

Hydrolysis, peptide aggregation, microbial growth

Prepare only volumes needed for near-term use

Reconstituted solution (frozen)

−20°C

Not recommended

Ice crystal disruption, aggregation

Freezing reconstituted peptide destroys structural integrity

Room temperature (any form)

20–25°C

24–72 hours

Rapid thermal denaturation, oxidation

Irreversible potency loss. Never store peptides at ambient temperature

Peptide stability in aqueous solution is exponentially temperature-dependent. The table above reflects empirical observations from accelerated stability studies. Your actual results will vary based on vial handling frequency, buffer composition, and local humidity conditions. When in doubt, store cagrilintide long term as lyophilised powder and reconstitute fresh aliquots every four weeks.

Key Takeaways

Store cagrilintide long term as lyophilised powder at −20°C with desiccant and light protection for up to 24 months of stability.

Reconstituted cagrilintide solution must be refrigerated at 2–8°C and used within 28 days. Potency declines 2–4% weekly after that point.

Temperature excursions above 8°C cause irreversible peptide denaturation that cannot be corrected by subsequent refrigeration.

Never freeze reconstituted peptide solutions. Ice crystal formation physically disrupts the amylin-mimetic structure and causes aggregation.

Moisture ingress during lyophilised storage reduces shelf life by 40–60%. Store vials in sealed containers with fresh desiccant packets.

Each freeze-thaw cycle reduces lyophilised peptide stability by 30–40% even if thermal excursions are brief.

What If: Cagrilintide Storage Scenarios

What If My Freezer Lost Power Overnight and the Lyophilised Cagrilintide Thawed?

Discard the vial if it reached room temperature for more than four hours. Lyophilised peptides that fully thaw undergo moisture absorption from ambient air, which triggers hydrolysis even if the powder appears dry. If your freezer remained below 0°C (partial thaw), the peptide likely retained 70–80% stability. You can continue using it but should reduce the expected shelf life from 24 months to 6–9 months and increase experimental concentrations by 20% to compensate for presumed potency loss. There's no visual indicator of peptide degradation in lyophilised form. Temperature logging is your only reliable evidence.

What If I Accidentally Left Reconstituted Cagrilintide Out of the Refrigerator for Three Hours?

Assume 15–25% potency loss and adjust your experimental dosing accordingly. Reconstituted peptide left at 15–20°C undergoes accelerated aggregation and partial denaturation. The solution may still appear clear because microaggregates remain suspended, but binding affinity to amylin receptors has decreased. Do not return the vial to the refrigerator and assume it's fine. Either increase your working concentration by 20–30% to account for reduced potency, or discard the solution and reconstitute a fresh aliquot. For critical assays where precise dosing matters, always discard after thermal excursions. The cost of repeating an experiment due to inconsistent peptide activity exceeds the cost of a new vial.

What If I Need to Store Cagrilintide Long Term for More Than 28 Days After Reconstitution?

You can't. Not reliably. Reconstituted peptide solutions degrade in aqueous buffer regardless of refrigeration temperature. After 28 days at 2–8°C, expect 10–15% potency loss; after 60 days, expect 30–40% loss. If your research protocol requires peptide availability over several months, store the compound as lyophilised powder and reconstitute fresh 5–10mg aliquots every four weeks. This approach maintains consistent potency across your study timeline and eliminates batch-to-batch variability caused by progressive degradation in solution.

The Cold Truth About Peptide Storage That Most Guides Won't Tell You

Here's the honest answer: most peptide degradation happens because researchers treat temperature ranges as suggestions rather than thresholds. A vial stored at 10°C instead of 2–8°C isn't slightly less stable. It's degrading three times faster. Every degree above 8°C doubles the rate of peptide hydrolysis and aggregation. Those storage guidelines aren't conservative estimates; they're the actual kinetic boundaries where structural integrity collapses.

The second truth: lyophilised peptides aren't indestructible just because they're dry. Moisture content below 3% by mass is critical for long-term stability, and achieving that requires active desiccation. Not just keeping the vial sealed. A lyophilised peptide stored without desiccant in a standard freezer will absorb enough water vapour through micro-leaks in the rubber stopper to lose 20–30% potency within six months. The degradation is invisible until you run the assay and your results don't replicate.

Finally: if you're purchasing peptides from suppliers who ship without cold-chain validation, you have no idea what thermal history your compound experienced. A vial that spent 12 hours at 25°C during ground shipping and then arrived cold doesn't regain stability just because it's cold now. At Real Peptides, every research-grade peptide ships with temperature data logging because thermal discipline begins before the compound ever reaches your lab. You can't store cagrilintide long term correctly if it arrives pre-degraded.

Storage conditions matter more than peptide purity. A 95% pure peptide stored correctly outperforms a 99% pure peptide stored carelessly every single time. Temperature monitoring isn't optional infrastructure. It's the minimum standard for peptide research that produces reproducible results.

Frequently Asked Questions

Lyophilised cagrilintide remains stable for 24 months when stored at −20°C in desiccated conditions with light protection. After 24 months, expect gradual potency decline of 5–10% per additional six months even under ideal storage. Moisture ingress or repeated freeze-thaw cycles reduce this timeline significantly — a vial exposed to ambient humidity or thawed once will lose 30–40% of its remaining shelf life regardless of subsequent storage correction.

No — freezing reconstituted peptide solutions causes ice crystal formation that physically disrupts the peptide backbone, leading to irreversible aggregation and loss of receptor binding activity. Once reconstituted, cagrilintide must remain refrigerated at 2–8°C and used within 28 days. If you need peptide availability beyond that window, store the compound as lyophilised powder and reconstitute fresh aliquots every four weeks rather than attempting to preserve a single reconstituted batch.

Temperature excursions above 8°C cause rapid and irreversible denaturation of the amylin-mimetic structure — disulphide bonds rearrange, beta-sheet regions misfold, and the peptide loses binding affinity to amylin receptors. A vial stored at 15°C for four hours typically loses 20–30% potency permanently, with no recovery possible through subsequent refrigeration. The solution may still appear clear because aggregation occurs at the molecular level, but pharmacological activity is compromised.

Shipping represents the highest-risk period for thermal excursions. A peptide vial that spends 12 hours at 25°C during ground transport loses 15–25% potency before it reaches your lab, even if it arrives cold. Without real-time temperature monitoring during transit, you have no way to verify the compound’s thermal history — which is why validated cold-chain shipping with data loggers is essential for peptides intended for precision research applications.

Yes — lyophilised peptides absorb water vapour through micro-leaks in rubber stoppers and around crimp seals even in sealed freezers. Moisture content above 3% by mass accelerates hydrolysis and oxidation, reducing shelf life by 40–60%. Store vials inside a sealed container with indicating silica gel desiccant, and replace the desiccant every three months or when the colour indicator changes from blue to pink, signalling moisture saturation.

No — peptide degradation occurs at the molecular level long before visible changes appear. Lyophilised powder retains its white appearance even after significant hydrolysis, and reconstituted solution remains clear despite microaggregate formation and potency loss. Temperature logging and adherence to storage timelines are the only reliable indicators of peptide integrity — visual inspection cannot detect structural denaturation or reduced receptor binding activity.

No — cagrilintide shows no measurable stability improvement at −80°C compared to −20°C, and ultra-low temperature storage increases the risk of sublimation-driven moisture ingress when vials are moved to working temperature. Standard laboratory freezers at −20°C provide adequate stability for 24 months when combined with desiccation and light protection. Ultra-low freezers are unnecessary and introduce handling complications without benefit.

Inject bacteriostatic water slowly down the inside wall of the vial rather than spraying it directly onto the lyophilised powder. Direct injection onto powder causes turbulent mixing and foam formation, both of which promote peptide aggregation through mechanical stress. After adding the solvent, gently swirl the vial — do not shake — and allow 2–3 minutes for complete dissolution. Vigorous agitation denatures peptide structures even before storage begins.

Request temperature data logging for every shipment — validated suppliers include real-time temperature monitors that record thermal conditions throughout transit. If a supplier cannot provide documented proof that your peptide remained within specification temperature ranges during shipping, assume thermal excursions occurred and potency is compromised. Cold packs alone are insufficient evidence; electronic logging is the minimum standard for research-grade peptide distribution.

Not reliably — each time you open the vial to remove an aliquot, you expose the remaining powder to ambient moisture, which accelerates degradation of what’s left. For protocols requiring multiple small-volume reconstitutions over months, request pre-aliquoted vials from your supplier rather than repeatedly opening one large container. Custom aliquoting under controlled atmosphere eliminates moisture exposure and preserves peptide integrity across all portions.